HeartChain will be a pioneer in providing decentralized, global sponsorship network designed specifically for the medical technology industry. HeartChain will remove funding hurdles for medical innovators, and speed up the time taken for new products to reach the market, where they start earning for their creators.
|Hard cap||34,000,000 USD|
|Whitepaper||Click Here For View Whitepaper|
|Website||Click Here For Visit ICO Homepage|
Global sponsorship network
HeartChain will be a pioneer in providing the very first de- The Value of HeartChain
centralized, global sponsorship network designed specifically for the medical technology industry. HeartChain will remove funding hurdles for medical innovators, and speed up the time taken for new products to reach the market, where they start earning for their creators. Sponsors will benefit by owning a tokenized version of the medical innovation, with the option to donate or sell with the option to donate the token back to the innovative company, or sell the token for the market price of the innovation.
HeartChain Corporation is the very first global, decentralized, blockchain-based sponsorship platform. It is designed specifically for medical product development, typically undertaken by medical technology companies. The company mission is to provide medical technology
innovators with a straightforward and quick means of finding sponsorship for product development, instead of the current cumbersome go-to-market process. The key vision of the company is to provide medical technology developers an alternate, non-security-based route to the traditional venture capital source of funding.
According to the World Health Organization, cardiovascular diseases continue to be the leading cause of death worldwide, with an estimated 17.7 million deaths occurring due to such diseases in 2015 alone, accounting for 31% of all global deaths. The American Heart Association further elaborated that cardiovascular diseases account for more than 800,000 deaths each year in the US, representing about one in every three deaths in the country,
2,300 deaths each day, or an average of one death every 38 seconds. The need to create solutions that can help prevent, control or even cure such diseases is immense.
Innovation lies at the heart of achieving sustainable healthcare and a better quality of life. This is the only way we can hope for more precise targeting of therapies to prevent, arrest, or cure illness. The founders of HeartChain, experts in the field of medicine and finance,
have a deep understanding of the problems that plague global healthcare, as well as the potential of crowdsale and blockchain technology in providing a powerful solution. What HeartChain also understand is that there are ordinary people and organizations across the world who are passionate about spurring innovation, but do not yet have the means to do.
HeartChain will first offer sponsorship opportunities in innovations for diseases of the heart and vascular tree. Heart and vascular tree diseases constitute the largest global health burdens while associated research has a larger spend than Cancer. This area is the fastest growing, and most potentially life-changing, sector of modern medicine. It is one in which the potential to radically change the quality and longevity of life is a true prospect.
HeartChain reduces friction in the flow of pipeline developments from new innovators. The combination of multiple sponsorship opportunities, experienced expert reviewers and the liberating benefits of blockchain, allows standardized cryptographic sponsorship to be
achieved in days, rather than months. HCT holders gain access to expert analysis on potential medical innovations.
HeartChain intend to fulfill this mission through the HeartChain token (HCT). Ownership of HCT grants rights to the token holder to participate on the HeartChain platform and view information and analysis usable in deciding whether to purchase the tokens of medical innovation products.The responsibility for creation and distribution of HCT will remain with HeartChain Corporation. The projectspecific tokens for innovating companies selected will follow a standard nomenclature, such as IPT# for Innovation Product Token 1, IPT#2, and so on.
Asher Holzer CHAIRMAN
Eytan Lombroso VICE CHAIRMAN
Jean-Marc Orlando VICE CHAIRMAN
Also Read – Click Here for Read All ICO Review
Quote This article is writing on 21 April 2019 based on information available online & news portal. If you feel it’s outdated or incorrect, please write here to update it. Mail us: email@example.com Or Whatsapp Us- +13098896258
Not all the websites Whi listed in Top List are 100% safe to use or investment. We do not promote any of those. Due diligence is your own responsibility. You should never make an investment in an online program with money you aren’t prepared to lose. Make sure to research the website. So Please take care of your investments. and be on the safe site and avoid much losing online.